ArticlePDF Available

Fucus vesiculosus: A nephrotoxic alga?

Authors:

Abstract and Figures

The therapeutic effect of alternative medicine is very often believed similar to that of conventional medicine, since many people think that 'natural' drugs are not dangerous for the health. Aim of this manuscript is to report the case of a young woman who presented acute renal failure as consequence of the use for three months of fucus vesiculosus tablets in order to lose weight. The chemical analysis of the fucus vesiculosus tablets showed the presence of high arsenic content.
Content may be subject to copyright.
Nephrol Dial Transplant (1998 ) 13: 526526
however, that patients with IgA nephropathy are at particular
tension when first seen by nephrologists.risk of developing pre-eclampsia.
We conclude that the present patient had underlying IgA In conclusion, the high mortality rate observed in our
patients is comparable to those reported in the literature.nephropathy associated with pre-eclampsia. We recommend
that renal biopsy be performed after severe and/or atypical Our series shows that MOF patients with lower hematocrit,
serum albumin or serum total protein, having sepsis or beingpre-eclampsia to reassess the renal risk of further pre-
eclampsia. oliguric, needing vasopressor drugs or mechanical ventilation
seem to have higher death rate. APACHE II score and the
Division of Nephrology Atsuhiro Yoshida number of OSF at the time of the initial renal consultation
Nagoya Daini Red Cross Hospital Kunio Morozumi appear to be useful in predicting the outcome in these
Third Department of Internal Asami Takeda patients. Survival seems to be negatively linked to the severity
Medicine Katsushi Koyama of associated diseases.
Nagoya City University Medical Yasuhiro Ohtsuka It would be desirable to start prospective multicentre
School Tadashi Oikawa studies with the purpose of determining patient characteristics
Nagoya, Japan and score systems applicable in predicting the outcome in
MOF patients with ARF.
Fresenius Medical Care Dialysis B. Csiky
Acute renal failure in patients with multiorgan failure:
Centre M. Molna
´r
risk factors influencing survival
2nd Department of Medicine A. Kara
´tson
Department of Anaesthesiology and L. Boga
´r
Sir, Intensive Care Unit
The mortality of acute renal failure (ARF ) still exceeds 50% University Medical School of Pe´cs
(it can reach up to 80% in Intensive Care Unit patients), Hungary
and so does the mortality of several forms of multiorgan
1. Wardle EN. Acute renal failure and multiorgan failure. Nephrol
failure (MOF ) [1 ]. Mortality of ARF seems to be determined
Dial Transplant 1994; 9[Suppl. 4 ]: 104–107
by the severity of associated diseases rather than by the ARF
2. Cosentino F, ChaC, Piedmonte M. Risk factors influencing
itself. Because of the high mortality rate and enormous
survival in ICU acute renal failure. Nephrol Dial Transplant 1994;
treatment costs, from early days much interest has been
9[ Suppl. 4]: 179 –182
shown in determining the prognosis of these patients. With
3. Liano F. Severity of acute renal failure: the need of measurement.
this aim, multiple aspects have been studied [ 2]. There is a
Nephrol Dial Transplant 1994; 9[Suppl. 4 ]: 229–238
debate in the literature about the usefulness of dierent
4. Douma CE, Redekop WK, van der Meulen JH et al. Predicting
mortality in intensive care patients with acute renal failure treated
patient characteristics and score systems in predicting the
with dialysis. J Am Soc Nephrol 1997; 8: 111 –117
outcome of ARF patients of Intensive Care Units ( ICU )
5. Groeneveld ABJ, Tran DD, van der Meulen JH, Nauta JJP,
[3,4 ]. The aim of the present study was to evaluate character-
Thijs LG. Acute renal failure in the medical intensive care unit:
istics and indices suited to predict mortality in MOF patients
predisposing, complicating factors and outcome. Nephron 1991;
with ARF.
59: 602–610
We studied retrospectively data of 39 patients with MOF
requiring renal replacement therapy, admitted consecutively
to the ICU of our Medical Centre from April 1, 1994 to
Fucus vesiculosus: a nephrotoxic alga?
December 31, 1996. This was a mixed population of medical
and surgical patients. All were treated with intermittent
haemodialysis carried out with cuprophan or polysulphone Sir,
In January 1995, a 18-year-old female was admitted to ourfilters. We considered only death or discharge from ICU as
valid outcomes. Student’s t-test and x2-test were used to unit because of polyuria and polydypsia. The patient com-
plained of extreme faintness and her general condition wasassess whether individual variables diered significantly
between survivors and non-survivors at a P<0.05. poor. The patient had been on a hypocaloric diet over the 3
months prior to the admittance and had actually lost ~10 kgThe overall mortality rate was 74.3%. The mean age of
the patients was 53±18.8 years. There was no dierence in in weight; as an adjunctive therapy prescribed by an herbalist,
she was also taking marine oak (fucus vesiculosus) in 400 mgage, gender, serum creatinine, urea nitrogen, serum potas-
sium, and blood pressure between survivors and non- tablets (three tablets three times a day). Her personal history
was negative for renal diseases and she denied any othersurvivors at the time of the initial renal consultation. The
APACHE II score at the time of the initial renal consultation medication. Laboratory testing revealed: blood creatinine,
8.7 mg/dl; glycosuria ( 500 mg/dl ); moderate proteinuria andwas significantly higher in non-survivors than in survivors
(28.8±5.50 vs 21.0±2.79, P<0.005). The number of organ leucocyturia; serum autoantibodies, negative. Renal sampling
performed by automatic Trucut needle yielded moderatesystem failure (OSF ) [5 ] was 2.4±0.97 in survivors and
3.1±0.90 in non-survivors (P<0.05). Survivors had higher interstitial fibrosis, widespread tubular degeneration, and
diuse lymphomonocytic infiltrate; the glomeruli displayedhematocrit (30.8±5.29 vs 24.6±4.87, P<0.05), higher serum
total protein (58.9±9.04 g/l vs 48.0±7.88 g/l, P<0.005) and scarce and focal mesangial proliferation, but the basal mem-
brane appeared as intact (Figure 1a). Direct IF testing wasserum albumim levels ( 31.9±2.52 g/l vs 27.4±4.31 g/l,
P<0.05) than non-survivors. Sepsis occurred in 45% of the negative. Positive peroxydase staining was obtained for
T-lymphocyte-related UCHL1 (CD45 RO) and monocyte-non-survivors and 30% of the survivors (P<0.01) . Sixty-two
per cent of the non-survivors and 40% of the survivors related KP1 (CD68 ) antibodies, respectively (Figure 1b, c).
To exclude contamination by heavy metals, we performed(P<0.01) were oliguric at the time of the initial renal
consultation. Forty-nine per cent of the survivors and 76% a quantitative analysis on the marine oak powder the tablets
were composed of. For this purpose, we used an atomicof the non-survivors needed mechanical ventilation
(P<0.01). Thirty per cent of the survivors and 56.8% of the adsorbance spectrophotometer ( Varian Spectra-20) supplied
with a graphite miniwave plus an autosampler; before testing,non-survivors received vasopressor drugs because of hypo-
at ULSS 6 Vicenza on March 22, 2016http://ndt.oxfordjournals.org/Downloaded from
Nephrol Dial Transplant (1998 ) 13: 527 527
cortical necrosis, but the most common pathologic feature is
interstitial fibrosis, tubular atrophy, and lymphomonocytic
infiltration [5,6 ] . In spite of a generally favourable prognosis,
some cases of residual functional impairment have been
described [7]. Our patient was completely cured 1 year after
the disease onset, and at present time she is in good health.
In our country, the lack of an adequate regulation about
the therapeutic sale of herbalistic products is probably based
upon the false conviction that ‘natural’ products are harmless
and that phytotherapy is henceforth to be preferred to
‘conventional’ medicine. In particular, the intake of marine
alga preparations as an adjuvant principle in slimming diets
has been progressively enhanced by the prescription-free sale.
Although a direct nephrotoxicity of this drug might hardly
be proven, its pathogenicity can be related to the content of
heavy metals as an heritage of growth in heavy polluted
water [8 ].
We hope that this report can stimulate the Italian Health
Authorities to request similar licensing procedures for both
synthetic drugs and ‘natural’ products.
Departments of Nephrology and P. A. Conz
Dialysis, G. La Greca
Infectious Diseases, and Institute of P. Benedetti
Pathology P. A. Bevilacqua
S. Bortolo Hospital L. Cima
Vincenza, Italy
Department of Pharmacology
Padova University
Italy
1. Appel GB, Kunis CL. Acute tubulo interstitial nephritis. In:
Cotran RS, ed. Tubulo-interstitial nephropathies. Churchill-
Livingstone, New York: 1982: 151–183
2. Brown MM, Rhyne BC, Goyer RA, Fowler BA. Intracellular
eects of chronic arsenic administration on renal proximal tubule
cells. J Toxicol Environ Health 1976; 1: 505–514
3. Fowler BA. The morphologic eects of mercury, cadmium, lead
and arsenic on the kidney. In: Trace Metals in Water Supplies:
Occurrence, Significance and Control. Proceedings Sixteenth water
quality conference. Champaign-Urbana: Department of
Engineering, University of Illinois: 1974; 65– 76
4. Kleinknicht D, Landais P, Goldfarb B. Drug associated acute
renal failure: a prospective multicenter report. Proceedings
EDTA–ERA 1988; 22: 1002
5. Prasad GVR, Rossi NF. Arsenic intoxication associated with
tubulo-interstitial nephritis. Am J Kidney Dis 1995; 26: 373–375
6. Gimenez A, Mampaso F. Characterization of inflammatory cells
in drug induced tubulointerstitial nephritis. Nephron 1986; 43: 239
7. Kida H, Abe T, Tomosugi M. Prediction of the long-term
outcome in acute interstitial nephritis. Clin Nephrol 1984; 22:
55–59
8. Rosemarin A, Notini M, Holmgren K. The fate of arsenic in the
Baltic Sea. Fucus vesiculosus ecosystem. Ambio 1985; 6: 342–345
(c)
(a)
(b)
Fig. 1. (a) Renal biopsy specimen showing moderate interstitial
fibrosis with widespread lymphomonocytic infiltrate (PAS 250×).
Feasibility of a native arteriovenous fistula as the initial
(b) Renal biopsy specimen: immunohistochemistry with UCHL 1
type of permanent vascular access in the majority of
(CD45RO) antibody showing interstitial T-lymphocytes (avidine-
biotin-peroxidase 250×). (c) Renal biopsy specimen: Antibody KP 1
chronic haemodialysis patients
(CD68) revealing interstitial monocytes (avidine-biotin-peroxidase
250×).
Sir,
The April 1997 issue of NDT brought two contributions
[1,2 ] concerning the impact of vascular access on morbiditysamples were pre-digested with concentrated nitric acid.
Chemical quantitative analysis gave the following results: and mortality of the chronic haemodialysis patients. Woods
and Port stated in an Editorial Comment [1] that despitearsenic, 21.3 mg/kg; cadmium, 0.3 ppm; mercury, 0.06 ppm;
and chrome, 4 ppm. evidence showing the superiority of a native AV fistula over
an AV graft because of lesser complication incidence and aThe real incidence of ‘heavy metal nephropathy’ is not
known because the clinical presentation is non-specific and longer life, a trend has been documented in the United States
away from use of an AV fistula and towards use of an AVrenal biopsy is necessary to confirm the diagnosis [1 –6 ].
Arsenic can evoke either an acute tubular necrosis or a graft. As a result <30% of the American patients [3] have
at ULSS 6 Vicenza on March 22, 2016http://ndt.oxfordjournals.org/Downloaded from
... 19,33 There is a single case report of renal dysfunction attributed to high levels of arsenic found in a bladderwrack preparation. 35 Arsenic is present in multiple kelp preparations, possibly as a result of growth in contaminated waters. 35,36 In one study, a patient presented with polydipsia, polyuria, proteinuria, and severe renal dysfunction after ingesting 1200 mg of bladderwrack daily for 3 months. ...
... 35 Arsenic is present in multiple kelp preparations, possibly as a result of growth in contaminated waters. 35,36 In one study, a patient presented with polydipsia, polyuria, proteinuria, and severe renal dysfunction after ingesting 1200 mg of bladderwrack daily for 3 months. 35 Renal biopsy revealed tubular degeneration and lymphomonocytic infiltration. ...
... 35,36 In one study, a patient presented with polydipsia, polyuria, proteinuria, and severe renal dysfunction after ingesting 1200 mg of bladderwrack daily for 3 months. 35 Renal biopsy revealed tubular degeneration and lymphomonocytic infiltration. One year after discontinuing the dietary supplement, the signs and symptoms of renal dysfunction had reversed. ...
... Par exemple, les composés arsenicaux organiques naturellement présents dans les poissons (principalement l'arsénobétaïne) sont excrétés très rapidement par l'homme et, de ce fait, il n'a pas été mentionné d'effets nocifs parmi les populations consommant des quantités importantes de poissons correspondant à un apport quotidien d'environ 50 µg/kg d'arsenic organique [73]. De façon surprenante, bien que l'arsenic présent dans les algues soit relativement non toxique pour l'homme (dérivés organiques majoritaires) en comparaison des dérivés inorganiques [77], il a été décrit des cas isolés de toxicoses potentielles dues à l'arsenic de compléments alimentaires à base de varech [78,79]. ...
... For instance, organoarsenic compounds, naturally occurring in fish (mainly arsenobetaine), are excreted very rapidly by man and there have been no reports of ill effects among populations whose consumption of large quantities of fish results in organoarsenical intakes of about 50 µg/kg per day [73]. Although the arsenic most commonly found in seaweed (organosugars) is relatively non-toxic to humans as compared to inorganic species [77], case reports of potential arsenic toxicosis secondary to kelp supplements intake have, surprisingly, been described [78,79]. ...
Article
Full-text available
The main source of available forms of heavy metals (toxic metals) for the plant kingdom is anthropogenic, resulting from diverse activities such as metallurgic processing of ore, cement plants, uncontrolled discharge of sewage sludge, burning of fossil fuels and waste incineration plants, and leaded petrol. Agricultural chemicals (e.g. phosphate fertilizers containing cadmium) may also contribute to the contamination of cultivated plants. The main threats to human health from toxic metals are associated with exposure to lead, cadmium, mercury (organic forms, especially methylmercury) and arsenic (mineral form only), which have no known vital or beneficial effect on living organisms. As their toxicity often takes years to manifest and may go unsuspected, their toxicological risk is defined on the basis of the so-called Provisional Tolerable Weekly Intake (PTWI) values. Beside anthropogenic causes, the main factors that may lead to high levels of toxic metals in medicinal plants are their availability in the soil with soil pH as the most important parameter for uptake by the plant. Indeed, genetic features of certain plant species show a tendency to accumulate certain trace elements, especially cadmium ("cadmium collector"). A very recent revision draft of the monograph "Herbal drugs" (Ph. Eur., 1433) includes acceptance criteria for lead, cadmium and mercury. This proposal is discussed in detail, based on literature data dealing with terrestrial plants and seaweed. Additionally, the need for inclusion of tests for inorganic impurities in quality control specification is examined, based on a risk assessment. As the daily intake of food supplements is very similar to the one of herbal remedies, it would be advisable to take into account the same acceptance criteria. The specific situation has also been considered of exotic herbal remedies, particularly those of Asian origin, which have been repeatedly reported to contain toxic levels of heavy metals and/or arsenic resulting in heavy metal poisoning.
... 21 When used in patients using nephrotoxic agents, because of a report of nephrotoxicity in a female taking F. vesiculosus tablets for weight loss (arsenic was found to be the cause). 24 When kombu seaweed (Laminaria japonica) is consumed at levels of 15 g or more daily by healthy nonallergic people, because of changes in thyroid hormone levels. 25 Likely unsafe-When used in patients with known allergy or hypersensitivity to any types or families of seaweed or their constituents. ...
... 45 When seaweed or seaweed supplements are used that were obtained from areas with known heavymetal or arsenic contamination, radiation exposure, or liver fluke (Fasciola hepatica) contamination, because of possible toxic or adverse effects. 24,[46][47][48][49][50][51][52][53] Notes-According to secondary sources, seaweed concentrates heavy metals found in the ocean, including arsenic, cadmium, and lead, and ingestion may increase the risk of heavymetal poisoning. Also, at high doses of iodine, a brassy taste, increased salivation, gastric irritation, and acneiform skin lesions may occur. ...
... Chronic interstitial nephritis has been described anecdotally following chronic ingestion of several botanicals. [31][32][33] Bladder-wrack (Fucus vesiculosus), a large brown alga, is a common food in Japan. It is used as a flavouring agent and dispensed as a drug in Europe. ...
... CKD due to interstitial nephritis has been described with long-term use of bladderwrack tablets. 32 Kwan et al. 33 described chronic interstitial nephritis in association with use of a Chinese herbal slimming pill containing anthraquinone derivatives extracted from Rhizoma Rhei (rhubarb). ...
Article
Full-text available
Alternative and indigenous systems of medicine are popular amongst the poorer sections of society in the developing world. Their use in the developed world has also increased in recent times. The source and composition of these medicines vary in different parts of the world, but herbs and other botanicals are central to these systems. Largely outside the ambit of regulatory control, herbal remedies are prepared by quasi-trained herbalists and not tested for safety. Toxicity can occur when a herb with unknown toxicity is consumed, incorrect identification leads to substitution of an innocuous herb with a toxic one, preparations are contaminated with toxic non-herbal compounds or when a herb potentiates the nephrotoxic effect of a conventional therapy. Renal injury has been reported in association with several herbs. The best-known herb-induced chronic kidney disease (CKD) is aristolochic acid nephropathy. The condition is characterized by progressive interstitial nephritis, with a proportion of patients developing urothelial malignancies. The toxic compound is aristolochic acid (AA); AA-DNA adducts have been identified in the renal and urothelial tissues. Recent evidence suggests that AA also contributes to the development of Balkan endemic nephropathy. The role of herbs has been postulated in the development of CKD in other parts of the developing world, especially amongst the rural population. Public awareness and regulation of use of herbal medicines are required to eradicate this entity from the community.
... CKD has been reported when bladderwrack tablets are consumed long term. 48 Similar manifestation of chronic decline of kidney function is noted when the Chinese herb rhubarb containing anthraquinone derivatives (Rhizoma rhei) is used as a slimming pill. 49 The autopsy of the famous music composer Ludwig van Beethoven revealed the presence of papillary necrosis. ...
Article
Traditional medicine refers to a diverse range of health and healing practices used by Indigenous peoples that incorporate plants, animals, and the spiritual realm for the diagnosis and treatment of illness or maintenance of health and well-being. While these practices hold significant cultural value, there is growing evidence of potential nephrotoxicity associated with some traditional indigenous medicines (TIMs). In this review, we explore the various clinical manifestations of nephrotoxicity induced by TIMs. Nephrotoxicity can result from various factors, including the intrinsic toxicity of certain herbs, contamination with heavy metals, inappropriate dosages, and interaction with conventional medications. This review highlights the importance of monitoring kidney function in patients using TIMs and calls for increased awareness and regulation to ensure the safe use of these traditional therapies.
Preprint
Full-text available
Criteria for diagnosing nephropathy and urothelial neoplasms induced by botanicals containing aristolochic acids (AAs) are well established. Highlights of recent research on AAs include mechanisms of AA intrarenal transport and metabolism and vigorous debate on whether AAs may also cause liver cancers. Many other botanicals may also cause renal injury, but a generalized framework for diagnosing botanical-induced kidney injury (BIKI) is lacking. Based on what we have learnt about the wide spectrum of phenotypes of BIKI attributed to AAs and a recently published standardized phenotypic framework of drug-induced kidney disease, we propose that BIKI may be categorized into six phenotypes (acute kidney injury, tubular dysfunction, glomerular disorders, nephrolithiasis, chronic kidney disease, and neoplasms) and four mechanistic types (A, predictable; B, idiosyncratic; C, chronic; and D, delayed). We call for international cooperation assembling a task force to develop, refine, and regularly appraise an online BIKI database, documenting botanical use, phenotypes, mechanisms, and levels of evidence. Once established, such a database may be linked with electronic patient records and pharmacovigilance channels to generate alerts, guide clinical decision-making, direct future research, and support evidence-based regulation of herbal medicines and education of healthcare professionals and the public. Finally, to prevent BIKI, we propose that a proactive approach integrating the triad of botanicals, users, and stakeholders will be needed.
Article
Globally, herbal medicines represent a $60 billion industry, and they account for approximately 20% of the overall drug market. Herbs (or herbals) that improve the taste of foods as flavor enhancement spices can generally be used safely by the CKD patient population. However, many herbals are sold as dietary supplements for medicinal use, and these are regulated as foods not drugs, thus allowing herbal supplements to be sold without premarket evaluation or approval by the Food and Drug Administration. In the absence of required testing, many herbal supplements are manufactured inconsistently with wide variations in composition. It is essential for the nephrology practitioner to assess CKD patients regarding their use of these products to understand their risks and benefits and to educate patients and families. This article will discuss some of the more commonly used products and their potential positive and adverse effects on CKD patients.
Article
Full-text available
Two new sesquiterpenes (1-2), and one diterpene (3) were isolated from the roots of Salvia palaestina Bentham (Lamiaceae), together with eight known diterpenes and two triterpenes. Their structures were elucidated by 1D and 2D NMR spectroscopy, including 1D-TOCSY, DQF-COSY, ROESY, HSQC, and HMBC experiments, as well as ESIMS and chemical analysis.
Article
Two new sesquiterpenes (1-2), and one diterpene (3) were isolated from the roots of Salvia palaestina Bentham (Lamiaceae), together with eight known diterpenes and two triterpenes. Their structures were elucidated by 1D and 2D NMR spectroscopy, including 1D-TOCSY, DQF-COSY, ROESY, HSQC, and HMBC experiments, as well as ESIMS and chemical analysis.
Article
The use of alternative medicine is highly prevalent around the world; in many areas, this is so because of lack of access to, or trust in, Western medicine, and also because they are considered "natural" and therefore safe. The kidney is an organ vulnerable to toxic insults by virtue of its anatomy and function. Reports of nephrotoxicity associated with alternative medicine use encompass all forms of renal dysfunction, ranging from electrolyte abnormalities and proteinuria to acute and CKD, renal failure, and death. In countries where intensive care and dialysis support are not available, mortality is high. Mechanisms of alternative medicine-associated kidney injury include direct nephrotoxicity, which may be augmented by underlying predisposing conditions such as dehydration; contamination, or adulteration of remedies; inappropriate use or preparation of a remedy; or interactions with other medications. The use of alternative medicines is underreported to clinicians. Because many patients strongly believe in the powers of alternative medicines, it is important that alternative medicines not be demonized as a whole, but that their use and consequences be closely observed and reported to build a more comprehensive understanding of their impact in our clinical practice and to foster research on the potential harm or, in some cases, possible benefits.
Article
Large quantities of arsenic are released into the environment, both through the mining of metals and the use of biocides. The arsenic may subsequently accumulate in organisms. This mesocosm experiment introduced arsenic into a simulated Baltic Sea littoral ecosystem. The results showed that the Fucus vesiculosus, a seaweed that provides shelter and food for macrofauna, and the sediment accumulated most of the arsenic. The total system was found to retain 27 percent of the arsenic introduced over a three-month period.
Article
Arsenic is one of the more common toxic elements in the environment. The kidney accumulates this element and plays a major role in its metabolism and excretion. Mitochondria have been found in vitro to be highly sensitive to the toxicity of this element. Combined oxygen electrode and electron microscopic studies were conducted on kidneys of rats exposed to arsenate in the drinking water at concentrations of 40, 85, or 125 ppm for 6 weeks to evaluate in vivo mitochondrial toxicity. Decreased state 3 respiration and respiratory control ratios were observed in kidneys of rats given the 85 and 125 ppm dose levels. Ultrastructural alterations, which consisted of swollen mitochondria and increased numbers of dense autophagic lysosome-like bodies, were confined to proximal tubule cells of these same animals. This study places renal arsenate mitochondrial toxicity into an in vivo context and points to the value of using complementary techniques for assessing the subacute or chronic toxicity of environmental agents.
Article
Fourteen patients with acute interstitial nephritis have been followed for an average of 64 months. Initial renal failure estimated by a reciprocal of serum creatinine improved rapidly and linearly within 6 to 8 weeks ("early improvement"). A slow improvement of GFR followed within one year, showing a new base line level of renal function, which was assessed as normal in five patients and was reduced in seven patients. Two patients died of non-renal disease. Final GFR was closely correlated with a degree of "early improvement", ages at onset and severity of interstitial lesions. The results suggest, 1) these indices are of much value in predicting long-term prognosis and 2) a certain degree of permanent impairment of renal function is rather common in the disease.
Article
Arsenic poisoning is an often unrecognized cause of renal insufficiency. We report a case of tubulointerstitial nephritis associated with an elevated urinary arsenic concentration, Removal of the putative source of arsenic resulted in symptomatic improvement, resolution of abnormal abdominal radiographs, and stabilization of renal function. This case emphasizes the importance of heavy metal screening in patients with multisystem complaints and tubulointerstitial nephritis. (C) 1995 by the National Kidney Foundation, Inc.
The morphologic effects of mercury, cadmium, lead and arsenic on the kidney
  • B A Fowler
Fowler BA. The morphologic effects of mercury, cadmium, lead and arsenic on the kidney. In: Trace Metals in Water Supplies: Occurrence, Significance and Control. Proceedings Sixteenth water quality conference. Champaign-Urbana: Department of Engineering, University of Illinois: 1974; 65-76
Drug associated acute renal failure: a prospective multicenter report
  • D Kleinknicht
  • P Landais
  • B Goldfarb
Kleinknicht D, Landais P, Goldfarb B. Drug associated acute renal failure: a prospective multicenter report. Proceedings EDTA-ERA 1988; 22: 1002